Lasix (Furosemide)

Furosemide blocks the Na⁺/K⁺/2Cl⁻ cotransporter in the thick ascending limb of the loop of Henle. This inhibition prevents reabsorption of sodium, potassium, and chloride, leading to increased excretion of these ions together with water (natriuresis and diuresis), which reduces extracellular fluid volume and blood pressure.

The appropriate dose of Lasix is individualized by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. Dosage may vary widely, and adjustments are made according to clinical monitoring and laboratory results.

Safety data for furosemide in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order Lasix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lasix belongs to the loop diuretic class, which is more potent than thiazide diuretics for removing large volumes of fluid. It acts on the loop of Henle, whereas thiazides act on the distal tubule. Loop diuretics are preferred for rapid diuresis in acute heart failure, whereas thiazides are often used for milder hypertension.

Lasix injectable solution should be stored below 25 °C, in its original packaging, protected from light and moisture. Do not freeze the product. Before administration, inspect the vial for particulate matter or discoloration and follow aseptic techniques as recommended for parenteral medicines.

Lasix is supplied as a sterile injectable solution for intramuscular (IM) or intravenous (IV) administration. The route, rate of infusion, and dilution are determined by the prescriber based on the clinical situation, such as acute pulmonary edema (IV push) or chronic fluid overload (IV infusion).

The most serious adverse events include severe hypotension, acute kidney injury, ototoxicity (especially with rapid IV infusion), and profound electrolyte disturbances such as hypokalemia or hyponatremia. Prompt monitoring of blood pressure, renal function, and electrolyte levels is essential to detect these complications early.

Lasix is contraindicated in patients with anuria (no urine output), known hypersensitivity to furosemide or other sulfonamide drugs, and in those with severe electrolyte depletion that cannot be corrected. Caution is also advised for patients with severe hepatic impairment, gout, or those taking medications that increase the risk of ototoxicity.